|
AHI1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.77460002038066E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.48949996781056E-09 |
| Normal-vs-Stage2 |
1.180350E-02 |
| Normal-vs-Stage3 |
1.470399999981E-06 |
| Normal-vs-Stage4 |
3.51450000000142E-05 |
| Stage1-vs-Stage2 |
1.483830E-01 |
| Stage1-vs-Stage3 |
7.267800E-01 |
| Stage1-vs-Stage4 |
3.945000E-01 |
| Stage2-vs-Stage3 |
2.125600E-01 |
| Stage2-vs-Stage4 |
4.157000E-01 |
| Stage3-vs-Stage4 |
6.534400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.16019996229977E-09 |
| Normal-vs-AfricanAmerican |
8.404300E-04 |
| Normal-vs-Asian |
5.694400E-01 |
| Caucasian-vs-AfricanAmerican |
3.628000E-01 |
| Caucasian-vs-Asian |
1.348790E-01 |
| AfricanAmerican-vs-Asian |
2.520600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.18530000154027E-08 |
| Normal-vs-Female |
2.87919999997222E-06 |
| Male-vs-Female |
3.554600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.201200E-04 |
| Normal-vs-Age(41-60Yrs) |
9.33080000042885E-07 |
| Normal-vs-Age(61-80Yrs) |
1.27360000323762E-08 |
| Normal-vs-Age(81-100Yrs) |
1.122160E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.086000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.185400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.137200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.694800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.844000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.690200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.120600E-01 |
| Normal-vs-Grade 2 |
4.48789999996091E-06 |
| Normal-vs-Grade 3 |
3.65980001859612E-09 |
| Normal-vs-Grade 4 |
8.03840000007661E-07 |
| Grade 1-vs-Grade 2 |
3.520600E-01 |
| Grade 1-vs-Grade 3 |
1.048370E-01 |
| Grade 1-vs-Grade 4 |
9.674200E-02 |
| Grade 2-vs-Grade 3 |
1.133200E-01 |
| Grade 2-vs-Grade 4 |
2.162400E-01 |
| Grade 3-vs-Grade 4 |
9.084600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.57310000004074E-06 |
| Normal-vs-ccB subtype |
1.91259999948734E-07 |
| ccA subtype-vs-ccB subtype |
4.181200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.60603000000092E-05 |
| Normal-vs-N1 |
1.218750E-03 |
| N0-vs-N1 |
1.996980E-01 |
|
|
